Sollis Therapeutics

Biotechnology, Medical, Pharmaceutical, Therapeutics
Founded in 2017-04-01
Columbus, Ohio, United States
http://www.sollistx.com/
For Profit

About Sollis Therapeutics

Sollis Therapeutics is a clinical-stage specialty pharmaceutical company developing novel non-steroid, non-opioid analgesics. Sollis’ first product is an extended-release combination analgesic and anti-inflammatory drug designed for local delivery for the treatment of sciatica and other neuropathic pain syndromes. The company was founded in 2017 and is headquartered in Columbus, Ohio.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 52500000 USD
  • Last Funding: 2500000 USD (Debt Financing)
  • Funding Status:

Technology Stack

Sollis Therapeutics actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Medical, Pharmaceutical, Therapeutics

Headquarters: Columbus, Ohio, United States